Our initial results, based upon both quantitative and qualitative evaluations of the efficacy and usability of Research-IQ, demonstrate its potential to increase clinical and translational research throughput.
We further use typical kernel examples with various computation and memory access patterns to assess the efficacy and usability of a set of promising approaches.
During early development in the Efficacy trial, usability tests were performed with 30 patients to solicit input on content, layout, and comprehension of material.
These measures will include PA behaviour, height and weight (to calculate the body mass index), Internet self-efficacy, website usability (only assessed at 3-month and 12-month follow-up periods), and quality of life.
Primary and secondary outcome measures will be assessed by self-report at baseline, 3 months and 12 months, and include: physical activity behaviour, height and weight, Internet self-efficacy, website usability, website usage and quality of life.
These findings confirm the efficacy and the usability worldwide of a consensus protocol for MOH management.
For example, even for repurposed drugs, safety, efficacy, quality, and usability must be demonstrated, either from prior knowledge or through newly generated data.
Background: This study investigated the efficacy, safety, and usability of standardized glycemic management by a computerized decision support system for non-critically ill hospitalized patients with type 2 diabetes on four different wards.
The purpose of this study was to investigate the efficacy, safety, and usability of a standardized glycemic management with the GlucoTab system for non-critically ill patients with type 2 diabetes mellitus.
